Chi-X adds global blue-chip US listed companies
Chi-X Australia, together with Deutsche Bank, has unveiled the next tranche of US listed companies that would be available to investors through its investment vehicle, Transferable Custody Receipts (TraCRs).
The new additions would include the following companies: Amazon, Warren Buffet’s conglomerate Berkshire Hathaway, Pfizer, Merck and Johnson & Johnson, making it a total of 15 global blue-chip US listed companies available to local investors on Chi-X Australia.
TraCRS trade in Australian dollars, on a local exchange and during Australian trading hours and provided investors with ownership of the underlying share which could be bought and sold like any domestic security.
“TraCRs have removed many of the traditional barriers to entry for those looking to access US equities and allow Australian investors to easily and cheaply trade well known, blue-chip brands on an Australian exchange,” Deutsche Bank’s head of depositary receipts Australia and New Zealand, Chris Bagley, said.
“Our partnership with Chi-X means we can be nimble in providing Australian investors with ongoing exposure to attractive global growth sectors.”
TraCRs are issued by Deutsche Access Investments Limited, a member of the Deutsche Bank group, and are exclusively traded on the Chi-X Australia exchange, accessible through a range of domestic brokers including CommSec, OpenMarkets, Morgans, Shaw and Partners and State One, the firm said.
AUTHOR
Oksana Patron
Recommended for you
Natixis Investment Managers has hired a distribution director to specifically focus on the firm’s work with research firms and consultants.
The use of total portfolio approaches by asset allocators is putting pressure on fund managers with outperformance being “no longer sufficient” when it comes to fund development.
With evergreen funds being used by financial advisers for their liquidity benefits, Harbourvest is forecasting they are set to grow by around 20 per cent a year to surpass US$1 trillion by 2029.
Total monthly ETF inflows declined by 28 per cent from highs in November with Vanguard’s $21bn Australian Shares ETF faring worst in outflows.
